Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$883M |
| 2 |
Boeing
BA
|
+$345M |
| 3 |
Salesforce
CRM
|
+$344M |
| 4 |
DexCom
DXCM
|
+$301M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$253M |
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$585M |
| 3 |
Home Depot
HD
|
+$264M |
| 4 |
Chubb
CB
|
+$263M |
| 5 |
PepsiCo
PEP
|
+$263M |
Sector Composition
| 1 | Technology | 16.53% |
| 2 | Healthcare | 15.07% |
| 3 | Financials | 14.94% |
| 4 | Industrials | 11.6% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
CNO Financial Group
CNO
$3.8B
| $15.1M | 0.01% |
662,019
-363,027
| -35% | -$8.3M |
|
1202
Ecovyst
ECVT
$1.06B
| $15.1M | 0.01% |
1,705,472
+245,466
| +17% | +$2.17M |
|
1203
AdaptHealth
AHCO
$1.26B
| $15.1M | 0.01% |
786,131
+645,281
| +458% | +$12.4M |
|
1204
Shoe Carnival
SCVL
$636M
| $15.1M | 0.01% |
630,822
+176,202
| +39% | +$4.21M |
|
|
RCFA
1205
DELISTED
Perception Capital Corp. IV
RCFA
| $15M | 0.01% |
1,464,970
+20,200
| +1% | +$207K |
|
1206
Rogers Communications
RCI
$19.3B
| $15M | 0.01% |
320,343
-1,776,086
| -85% | -$83.2M |
|
1207
Capital Southwest
CSWC
$1.27B
| $15M | 0.01% |
875,326
+165,544
| +23% | +$2.83M |
|
1208
Franklin Covey
FC
$240M
| $15M | 0.01% |
319,958
+7,065
| +2% | +$330K |
|
|
VRTV
1209
DELISTED
VERITIV CORPORATION
VRTV
| $15M | 0.01% |
122,920
-100,612
| -45% | -$12.2M |
|
1210
Hercules Capital
HTGC
$3.53B
| $14.9M | 0.01% |
1,127,897
-366,668
| -25% | -$4.85M |
|
|
ACDI
1211
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
| $14.9M | 0.01% |
1,440,000
| – | – |
|
1212
Terns Pharmaceuticals
TERN
$633M
| $14.8M | 0.01% |
1,457,205
+1,074,492
| +281% | +$10.9M |
|
|
CPAR
1213
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
| $14.8M | 0.01% |
1,471,308
+138,793
| +10% | +$1.4M |
|
1214
Warrior Met Coal
HCC
$3.04B
| $14.8M | 0.01% |
427,377
+378,214
| +769% | +$13.1M |
|
|
EBIX
1215
DELISTED
Ebix Inc
EBIX
| $14.8M | 0.01% |
741,381
+302,485
| +69% | +$6.04M |
|
|
NAAC
1216
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
| $14.8M | 0.01% |
1,463,464
-100
| -0% | -$1.01K |
|
1217
SSR Mining
SSRM
$4.54B
| $14.8M | 0.01% |
943,408
+580,346
| +160% | +$9.09M |
|
|
ADAL
1218
DELISTED
Anthemis Digital Acquisitions I Corp Class A Ordinary Shares
ADAL
| $14.8M | 0.01% |
1,439,930
+14,930
| +1% | +$153K |
|
|
NXRT
1219
NexPoint Residential Trust
NXRT
$858M
| $14.8M | 0.01% |
339,278
+172,386
| +103% | +$7.5M |
|
|
HCMA
1220
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
| $14.7M | 0.01% |
1,426,950
| – | – |
|
1221
Fluence Energy
FLNC
$917M
| $14.7M | 0.01% |
859,436
+617,753
| +256% | +$10.6M |
|
|
AHRN
1222
DELISTED
Ahren Acquisition Corp. Class A Ordinary Shares
AHRN
| $14.7M | 0.01% |
1,439,990
| – | – |
|
1223
iShares MSCI Japan ETF
EWJ
$15.7B
| $14.7M | 0.01% |
270,688
+265,236
| +4,865% | +$14.4M |
|
1224
Wolverine World Wide
WWW
$2.48B
| $14.7M | 0.01% |
1,347,482
+1,270,099
| +1,641% | +$13.9M |
|
1225
Protagonist Therapeutics
PTGX
$3.66B
| $14.7M | 0.01% |
1,345,389
+1,147,367
| +579% | +$12.5M |
|